On this edition of NewlyTrading, Terry Howlett, CEO of Ovation Science Inc. (OVAT:CSE) explains the path that led to Ovation's listing... and how his company's skincare expertise is leading to patented medicinal CBD release products that work.
Vancouver, BC – November 15, 2018 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) announces that it has closed its Initial Public Offering of units at $0.30 per unit (the “Units”) pursuant to its final prospectus dated October 26, 2018 (the “Prospectus”).
Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system called Invisicare®, today announces the formation of its Ovation Science, Inc. subsidiary, and the company's definitive license agreement with Lighthouse Strategies...
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) and Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system, today announce they have signed a definitive license agreement for...
